Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.871
+0.010 (1.16%)
At close: May 2, 2024, 2:17 PM
0.880
+0.009 (1.03%)
After-hours: May 2, 2024, 4:56 PM EDT

Xtant Medical Holdings Revenue

In the year 2023, Xtant Medical Holdings had annual revenue of $91.30M with 57.50% growth. Revenue in the quarter ending December 31, 2023 was $28.11M with 84.07% year-over-year growth.

Revenue (ttm)
$91.30M
Revenue Growth
+57.50%
P/S Ratio
1.23
Revenue / Employee
$441,077
Employees
207
Market Cap
112.49M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.30M33.33M57.50%
Dec 31, 202257.97M2.71M4.90%
Dec 31, 202155.26M1.93M3.61%
Dec 31, 202053.34M-11.35M-17.54%
Dec 31, 201964.68M-7.52M-10.42%
Dec 31, 201872.20M-10.41M-12.60%
Dec 31, 201782.61M-7.39M-8.21%
Dec 31, 201690.00M30.66M51.66%
Dec 31, 201559.35M24.01M67.97%
Dec 31, 201435.33M2.26M6.83%
Dec 31, 201333.07M93.52K0.28%
Dec 31, 201232.98M2.83M9.39%
Dec 31, 201130.15M14.73M95.55%
Dec 31, 201015.42M8.02M108.53%
Dec 31, 20097.39M6.93M1,509.98%
Dec 31, 2008459.23K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 339.44M
FibroGen 147.75M
Karyopharm Therapeutics 146.03M
Abeona Therapeutics 3.50M
GlycoMimetics 10.00K
Revenue Rankings